146 results
8-K
EX-99.1
SEEL
Seelos Therapeutics Inc
19 Mar 24
Other Events
4:05pm
research and in caring for the ALS community. Their unique and innovative approach continues to be a benefit to the ALS community and its contributions … and discussions with the FDA, statements regarding The Sean M. Healey and AMG Center’s contributions to the ALS community, statements regarding
424B3
SEEL
Seelos Therapeutics Inc
15 Mar 24
Prospectus supplement
4:15pm
Stockholders have sole voting and investment power with respect to all Shares beneficially owned, subject to applicable community property laws … of computing the percentage ownership of any other person.
Unless otherwise indicated and subject to applicable community property laws, to our
424B5
3vabhj8q5e
30 Jan 24
Prospectus supplement for primary offering
6:05am
8-K
EX-99.1
86wl94x4jg tm2eg2yu3
22 Jan 24
Other Events
8:05am
DEFA14A
h1bih1y
22 Dec 23
Additional proxy soliciting materials
4:01pm
424B5
51y6g9qk jh28d9pp
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
3to3n
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B3
gkkjbj z2
29 Sep 23
Prospectus supplement
4:56pm
424B5
k3ce5fe
25 Sep 23
Prospectus supplement for primary offering
6:02am
8-K
EX-99.1
pzfy4nbr
20 Sep 23
Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide
7:00am